Delaware stem cell research gets $916,577 boost

The Lisa Dean Moseley Foundation has awarded Senior Research Scientist Bruce Boman, of Christiana Care’s Helen F. Graham Cancer Center & Research Institute, a $916,577 grant to further stem cell research of colon cancer, DelawareBio has announced.

#DEBIO #member Bruce Boman at the Helen F. Graham Cancer Center & Research Institute of @christianacare, has received a $916,577 grant award from the Lisa Dean Moseley Foundation to further #stemcell #research into the origins of colon #cancer https://t.co/zNagMJuLbM #netDE pic.twitter.com/4aS8azpykg

— Delaware Bio (@Delaware_Bio) February 4, 2019

Some additional details from Onco’Zine, the publication of the International Oncology Network:

“Boman’s team will take a multidisciplinary approach drawn from tumor biology, cancer genetics, pathology, medical oncology and molecular biology to discover how stem cells are regulated in the normal healthy colon and how gene mutations contribute to stem cell overpopulation in tumors. Specifically, they will study how inactivation of the adenomatous polyposis coli (APC) tumor suppressor gene leads to stem cell overpopulation that drives colon cancer development and growth.”

The Wilmington-based Lisa Dean Moseley Foundation, a legacy of the du Pont heiress, has a mission to support stem cell research.